Medinova Diagnostic Services Ltd.
BSE: 526301 | Sector: Health care |
NSE: N.A. | ISIN Code: INE047C01019 |
BSE 15:15 | 03 Feb | 24.30 |
0.05 (0.21%) |
OPEN
24.30 |
HIGH
24.30 |
LOW
24.30 |
NSE 05:30 | 01 Jan | Medinova Diagnostic Services Ltd |
OPEN | 24.30 |
PREVIOUS CLOSE | 24.25 |
VOLUME | 200 |
52-Week high | 43.75 |
52-Week low | 22.00 |
P/E | 51.70 |
Mkt Cap.(Rs cr) | 24 |
Buy Price | 24.30 |
Buy Qty | 1.00 |
Sell Price | 25.15 |
Sell Qty | 500.00 |
Medinova Diagnostic Services Ltd. (MEDINOVADIAGNO) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Cipla | 1025.50 | 0.55 | 0.05 | 2957.93 |
Divi's Lab. | 2880.00 | -387.15 | -11.85 | 2948.54 |
Glenmark Pharma. | 385.40 | -3.85 | -0.99 | 1997.79 |
Glaxosmi. Pharma | 1246.70 | 11.25 | 0.91 | 1690.53 |
Dr Reddy's Labs | 4358.35 | -11.70 | -0.27 | 1623.20 |
Alkem Lab | 3059.00 | -15.60 | -0.51 | 1541.25 |
Aurobindo Pharma | 404.20 | -5.70 | -1.39 | 1454.71 |
Gland Pharma | 1209.50 | -66.45 | -5.21 | 1212.16 |
Torrent Pharma. | 1533.45 | -7.25 | -0.47 | 991.45 |
Sanofi India | 5350.05 | -66.80 | -1.23 | 944.40 |
Ipca Labs. | 856.30 | -0.20 | -0.02 | 870.94 |
Zydus Lifesci. | 435.15 | 2.55 | 0.59 | 857.90 |
Abbott India | 20907.25 | 423.10 | 2.07 | 798.70 |
Laurus Labs | 331.35 | -7.45 | -2.20 | 750.09 |
Ajanta Pharma | 1174.90 | -14.65 | -1.23 | 719.86 |
Apollo Hospitals | 4249.55 | 16.55 | 0.39 | 665.20 |
Pfizer | 3879.65 | 26.60 | 0.69 | 612.56 |
Suven Pharma | 485.00 | -3.20 | -0.66 | 558.10 |
Alembic Pharma | 534.55 | -5.65 | -1.05 | 543.55 |
Glenmark Life | 377.30 | -3.10 | -0.81 | 418.72 |
Quick Links for Medinova Diagnostic Services:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices